Skip to content
Trial Eligibility
Menu

A Study to Assess the Efficacy and Safety of Elismetrep (K-304) in the Acute Treatment of Migraine

NCT07816367

This study is recruiting at 36 US sites in 15 states, according to its ClinicalTrials.gov record last updated .

Summary

This is a double-blind, randomized, multicenter, outpatient evaluation of the safety and efficacy of elismetrep, as compared with placebo, in the treatment of moderate or severe of migraine.

Shortened from the sponsor's brief summary. View official record on ClinicalTrials.gov

Conditions studied

  • Migraine

Eligibility basics and study details

Study type
Interventional
Phase
Phase 3
Ages
18 to 75 years
Sex
All
Healthy volunteers
Not accepted
Sponsor
Kallyope Inc.
Last updated on ClinicalTrials.gov
October 14, 2026

These are the basic criteria only. The full inclusion and exclusion criteria are on the official record, and the study team decides who can take part.

US recruiting sites

Arizona · 2

  • IMA Clinical Research - Phoenix · Phoenix, AZ
  • Velocity Clinical Research, Phoenix · Phoenix, AZ

California · 7

  • Alliance Research Institute, Canoga Park · Canoga Park, CA
  • Velocity Clinical Research, Chula Vista · Chula Vista, CA
  • Neurology Center of North Orange County · Fullerton, CA
  • Accellacare - Long Beach · Long Beach, CA
  • Long Beach Clinical Trials Services, Inc · Long Beach, CA
  • Paradigm Clinical Research Centers, LLC · San Diego, CA
  • Optimus Medical Group · San Francisco, CA

Colorado · 1

  • Paradigm Clinical Research Centers, LLC; Aurora · Aurora, CO

Florida · 4

  • Clinical Research of Central Florida · Lakeland, FL
  • Sensible Healthcare, LLC · Ocoee, FL
  • Clinical Associates of Orlando, LLC · Orlando, FL
  • Cenexel Tampa FL · Tampa, FL

Georgia · 1

  • Clinical Integrative Research Center of Atlanta · Atlanta, GA

Illinois · 1

  • Clinical Investigation Specialists, Inc. · Gurnee, IL

Iowa · 1

  • Accellacare - McFarland | · Ames, IA

Massachusetts · 1

  • Neurology Center of New England P.C. · Foxborough, MA

North Carolina · 4

  • Accellacare - Cary (Cary Medical Group) · Cary, NC
  • West Clinical Research · Morehead City, NC
  • Accellacare - Wilmington · Wilmington, NC
  • Accellacare - Winston-Salem · Winston-Salem, NC

North Dakota · 1

  • Lillestol Research · Fargo, ND

Ohio · 3

  • Velocity Clinical Research, Cleveland · Beachwood, OH
  • Headache Center of Hope · Cincinnati, OH
  • Centricity Research; Columbus, Ohio · Columbus, OH

Rhode Island · 1

  • Velocity Clinical Research, Providence · Providence, RI

South Carolina · 1

  • Velocity Clinical Research, Anderson · Anderson, SC

Texas · 7

  • Central Texas Clinical Research · Austin, TX
  • Velocity Clinical Research, Dallas · Dallas, TX
  • Newco 3A Researh LLC, DBA 3A Research · El Paso, TX
  • Red Star Research · Lake Jackson, TX
  • Clinical Trials of Texas, LLC, A Flourish Research Site · San Antonio, TX
  • DM Clinical Research, Sugar Land · Sugar Land, TX
  • DM Clinical Research, Tomball · Tomball, TX

Utah · 1

  • Highland Clinical Research · Salt Lake City, UT

Source: ClinicalTrials.gov, data processed . Recruiting US sites filtered by distance and site status; summaries shortened.